Clinical Trial

A Clinical Trial to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn about the effects of AP-Brain collagen peptide on attention, focus, and memory in adults who are stressed but otherwise healthy. The main questions it aims to answer are: * How does AP-Brain affect a participant's attention, focus, stress, and memory? * Is there a difference in the effects between a higher dose and a lower dose? * What are the side effects, if any, for participants taking AP-Brain? Researchers will compare two different doses of AP-Brain to see how they affect brain function and stress levels. Participants in this study will be asked to: * Take one of two the doses of AP-Brain once a day for 56 days. * Visit the study center for regular checkups. * Complete tasks that measure memory, focus, and attention. * Answer survey questions about their stress levels. * Provide blood samples and have vital signs checked. * Have the brain's response to tasks monitored to see how it affects attention and alertness.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-22
notable Primary completion pushed: 2026-10 -> 2026-11 2026-07-22
minor Completion pushed: 2026-10 -> 2026-11 2026-07-22
Trial Details
NCT Number NCT07572240
Lead Sponsor Rousselot BVBA
Collaborators: Vedic Lifesciences Pvt. Ltd.
Conditions Healthy, Stress
Enrollment 72 participants
Start Date 2026-07-27
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-23